interstitial lung disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meet the western medicine diagnosis of the disease; 2. Meet the TCM diagnosis and syndrome differentiation standards of this disease; 3. The patient voluntarily accepted the treatment and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Age> 80 years old; 2. Combined with tuberculosis, fungus, tumor, etc. and other primary lung diseases; 3. Patients with severe complications of other diseases such as cardiovascular, urinary, digestive, hematopoietic, endocrine and metabolic systems, liver and kidney insufficiency, and mental illness; 4. Pregnant or lactating women and those who are known to be allergic to the components of this medicine; 5. Those who fail to use the prescribed drugs and follow the doctor's advice, cannot judge the curative effect or whose clinical data is incomplete and affect the judgment; 6. Participating in other drug clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| lung function;HRCT change point;symptom score;PaO2; | — |
Secondary
| Measure | Time frame |
|---|---|
| MRC score;the change score of ATAQ-IPF; | — |
Countries
China
Contacts
Shanghai Pulmonary Hospital